GlassScriptPhysician profile
Corey W Wesner
NPI 1861493967
$8,889.77
in general payments reported to CMS, 2019-2025
20 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $2,636 · 2021: $4,447 · 2022: $955 · 2023: $126 · 2024: $106 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,333.08 | 2020-2021 | |
| Great Lakes Orthopedics | $2,774.20 | 2019-2021 | |
| Treace Medical Concepts, INC. | $1,493.26 | 2021-2023 | |
| Paragon 28, INC. | $178.59 | 2021 | |
| Bone Support INC. | $155.90 | 2025 | Cerament G, Ceramentbone Void Filler |
| Stryker Corporation | $134.09 | 2022-2024 | Anchorage |
| Trilliant Surgical LLC. | $131.54 | 2019 | |
| Linvatec Corporation | $124.97 | 2025 | Biobrace 23mm |
| Smith+Nephew, INC. | $119.18 | 2019-2023 | Oasis |
| Depuy Synthes Sales INC. | $112.31 | 2020-2024 | Motoband, Fibergraft Aeridyan Matrix |
| Organogenesis INC. | $103.12 | 2021-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $73.55 | 2021-2025 | Nuzyra |
| Nevro Corp. | $39.50 | 2022-2023 | Senza |
| Orthofix Medical, INC. | $21.18 | 2024 | Accelstim |
| Kci USA, INC. | $19.24 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $18.93 | 2025 | Purified Cortrophin Gel |
| Mimedx Group, INC. | $16.13 | 2025 | |
| Pfizer INC. | $15.26 | 2019 | |
| Apria Healthcare LLC | $14.74 | 2021 | |
| Celularity INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Wesner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.